Mineralocorticoid radioreceptor assay: Application to adrenal-regeneration hypertension

Celso Gomez-Sanchez, O. Bryan Holland, Barbara A. Murry

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Identification of unknown hormones has traditionally involved utilizing a bioassay to initially detect the hormone and to follow its purification. However, radioreceptor assays may be more useful for this purpose by offering greater sensitivity and precision. A mineralocorticoid radioreceptor assay has been developed for use in conjunction with chromatographic separation of a urinary extract to detect the presence of unknown urinary mineralocorticoids. This assay utilizes competition of the unknown steroid and aldosterone for rat renal cytoplasmic mineralocorticoid receptors to enable mineralocorticoid quantitation in aldosterone equivalents. This assay provides 100 fold increase in sensitivity and a significant increase in precision over the commonly used adrenalectomized rat bioassay. The mineralocorticoid radioreceptor assay has been utilized to assay mineralocorticoid activity in chromatographic fractions of a urinary extract from rats with regenerating adrenals. A large area of mineralocorticoid radioreceptor activity has been identified which possibly represents an unknown mineralocorticoid contributing to the etiology of adrenal regeneration hypertension. This assay is applicable to other syndromes of postulated unknown mineralocorticoid excess, such as human low renin essential hypertension. In addition, similar radioreceptor assays are applicable for the initial detection of any type of hormone activity and for the subsequent purification and identification of this hormone.

Original languageEnglish (US)
Pages (from-to)989-995
Number of pages7
JournalLife Sciences
Volume21
Issue number7
DOIs
StatePublished - Oct 1 1977

Fingerprint

Mineralocorticoids
Radioligand Assay
Regeneration
Assays
Hypertension
Hormones
Rats
Bioassay
Aldosterone
Biological Assay
Purification
Mineralocorticoid Receptors
Cytoplasmic and Nuclear Receptors
Renin
Steroids
Kidney

ASJC Scopus subject areas

  • Pharmacology

Cite this

Mineralocorticoid radioreceptor assay : Application to adrenal-regeneration hypertension. / Gomez-Sanchez, Celso; Holland, O. Bryan; Murry, Barbara A.

In: Life Sciences, Vol. 21, No. 7, 01.10.1977, p. 989-995.

Research output: Contribution to journalArticle

Gomez-Sanchez, Celso ; Holland, O. Bryan ; Murry, Barbara A. / Mineralocorticoid radioreceptor assay : Application to adrenal-regeneration hypertension. In: Life Sciences. 1977 ; Vol. 21, No. 7. pp. 989-995.
@article{31327f9e7faf42fa9fd52e1450d3867e,
title = "Mineralocorticoid radioreceptor assay: Application to adrenal-regeneration hypertension",
abstract = "Identification of unknown hormones has traditionally involved utilizing a bioassay to initially detect the hormone and to follow its purification. However, radioreceptor assays may be more useful for this purpose by offering greater sensitivity and precision. A mineralocorticoid radioreceptor assay has been developed for use in conjunction with chromatographic separation of a urinary extract to detect the presence of unknown urinary mineralocorticoids. This assay utilizes competition of the unknown steroid and aldosterone for rat renal cytoplasmic mineralocorticoid receptors to enable mineralocorticoid quantitation in aldosterone equivalents. This assay provides 100 fold increase in sensitivity and a significant increase in precision over the commonly used adrenalectomized rat bioassay. The mineralocorticoid radioreceptor assay has been utilized to assay mineralocorticoid activity in chromatographic fractions of a urinary extract from rats with regenerating adrenals. A large area of mineralocorticoid radioreceptor activity has been identified which possibly represents an unknown mineralocorticoid contributing to the etiology of adrenal regeneration hypertension. This assay is applicable to other syndromes of postulated unknown mineralocorticoid excess, such as human low renin essential hypertension. In addition, similar radioreceptor assays are applicable for the initial detection of any type of hormone activity and for the subsequent purification and identification of this hormone.",
author = "Celso Gomez-Sanchez and Holland, {O. Bryan} and Murry, {Barbara A.}",
year = "1977",
month = "10",
day = "1",
doi = "10.1016/0024-3205(77)90266-1",
language = "English (US)",
volume = "21",
pages = "989--995",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Mineralocorticoid radioreceptor assay

T2 - Application to adrenal-regeneration hypertension

AU - Gomez-Sanchez, Celso

AU - Holland, O. Bryan

AU - Murry, Barbara A.

PY - 1977/10/1

Y1 - 1977/10/1

N2 - Identification of unknown hormones has traditionally involved utilizing a bioassay to initially detect the hormone and to follow its purification. However, radioreceptor assays may be more useful for this purpose by offering greater sensitivity and precision. A mineralocorticoid radioreceptor assay has been developed for use in conjunction with chromatographic separation of a urinary extract to detect the presence of unknown urinary mineralocorticoids. This assay utilizes competition of the unknown steroid and aldosterone for rat renal cytoplasmic mineralocorticoid receptors to enable mineralocorticoid quantitation in aldosterone equivalents. This assay provides 100 fold increase in sensitivity and a significant increase in precision over the commonly used adrenalectomized rat bioassay. The mineralocorticoid radioreceptor assay has been utilized to assay mineralocorticoid activity in chromatographic fractions of a urinary extract from rats with regenerating adrenals. A large area of mineralocorticoid radioreceptor activity has been identified which possibly represents an unknown mineralocorticoid contributing to the etiology of adrenal regeneration hypertension. This assay is applicable to other syndromes of postulated unknown mineralocorticoid excess, such as human low renin essential hypertension. In addition, similar radioreceptor assays are applicable for the initial detection of any type of hormone activity and for the subsequent purification and identification of this hormone.

AB - Identification of unknown hormones has traditionally involved utilizing a bioassay to initially detect the hormone and to follow its purification. However, radioreceptor assays may be more useful for this purpose by offering greater sensitivity and precision. A mineralocorticoid radioreceptor assay has been developed for use in conjunction with chromatographic separation of a urinary extract to detect the presence of unknown urinary mineralocorticoids. This assay utilizes competition of the unknown steroid and aldosterone for rat renal cytoplasmic mineralocorticoid receptors to enable mineralocorticoid quantitation in aldosterone equivalents. This assay provides 100 fold increase in sensitivity and a significant increase in precision over the commonly used adrenalectomized rat bioassay. The mineralocorticoid radioreceptor assay has been utilized to assay mineralocorticoid activity in chromatographic fractions of a urinary extract from rats with regenerating adrenals. A large area of mineralocorticoid radioreceptor activity has been identified which possibly represents an unknown mineralocorticoid contributing to the etiology of adrenal regeneration hypertension. This assay is applicable to other syndromes of postulated unknown mineralocorticoid excess, such as human low renin essential hypertension. In addition, similar radioreceptor assays are applicable for the initial detection of any type of hormone activity and for the subsequent purification and identification of this hormone.

UR - http://www.scopus.com/inward/record.url?scp=0017662550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017662550&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(77)90266-1

DO - 10.1016/0024-3205(77)90266-1

M3 - Article

C2 - 22013

AN - SCOPUS:0017662550

VL - 21

SP - 989

EP - 995

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 7

ER -